Lucite tombstone marking an acquisition by Oxygen Biotherapeutics, now known as Tenax Therapeutics.
(4ASHOIF)
Lucite tombstone marking an acquisition by Oxygen Biotherapeutics, now known as Tenax Therapeutics.
(4ASHOIF)Custom Biotech Corporate Tombstone recognizing the merger of Antitope and PolyTherics. Antitope was advised by London-based Ferghana Partners Group.
(3LMJOAQ)Financial tombstone marking the initial public offering of stock by Cambridge, Massachusetts-based biotech firm Bluebird. The company focuses on gene therapies addressing both genetic and orphan diseases.
(3AHH048)Custom tombstone marking the acquisition of Israeli firm Prolor Biotech. The acquiring company was Miami-based pharmaceutical and biotechnology firm Opko Health.
Lucite deal toy recognizing two stock offerings by Oxygen Biotherapuetics. The specialty pharmaceutical firm, now known as Tenax Therapeutics, is based in Morrisville, North Carolina.
(3ASH0BF)Financial tombstone recognizing the private placement of shares in Bionor Pharma. Headquartered in Oslo, Norway, the firm specializes in vaccines aimed at rapidly mutating virus infections such as HIV and Influenza.
Custom biotech acquisition deal toy recognizing the acquisition of BioBehavioral Diagnostics Company (BioBDX). The firm was acquired by educational and business publisher Pearson.
Job: 3AJS09D
